Not applicableUnknownNCT00847756What this trial is testingHost-pathogen Interaction in Otitis MediaWho this might be right forOtitis Media Radboud University Medical Center 179
Post-approval studies (Phase 4)Study completedNCT00254917What this trial is testingAssessment of the Immunogenicity and Safety of PENTAXIM™ in PhilippinesWho this might be right forDiphtheriaTetanusPolio+2 more Sanofi 387
Post-approval studies (Phase 4)Study completedNCT01358825What this trial is testingStudy to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™Who this might be right forTetanusPoliomyelitisHaemophilus Influenzae Type b+4 more GlaxoSmithKline 58
Large-scale testing (Phase 3)Study completedNCT00404651What this trial is testingLot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy InfantsWho this might be right forDiphtheriaTetanusPertussis+2 more Sanofi Pasteur, a Sanofi Company 1,189
Large-scale testing (Phase 3)Study completedNCT00228917What this trial is testingSafety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in ChildrenWho this might be right forWhole Cell PertussisTetanusHepatitis B+3 more GlaxoSmithKline 798
Large-scale testing (Phase 3)Study completedNCT00316147What this trial is testingImmunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination SchedulesWho this might be right forDiphtheriaAcellular PertussisTetanus+3 more GlaxoSmithKline 224
Post-approval studies (Phase 4)Study completedNCT00674908What this trial is testingPhase IV Interchangeability Study of a Liquid Pentavalent Combination VaccineWho this might be right forDiphtheriaTetanusPertussis+2 more Shantha Biotechnics Limited 144
Large-scale testing (Phase 3)Study completedNCT01411241What this trial is testingStudy of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy ToddlersWho this might be right forDengueDengue Hemorrhagic Fever Sanofi Pasteur, a Sanofi Company 720
Post-approval studies (Phase 4)Study completedNCT01138098What this trial is testingEvaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated ChildrenWho this might be right forHepatitis B GlaxoSmithKline 185
Large-scale testing (Phase 3)Study completedNCT00289783What this trial is testingSafety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccineWho this might be right forHaemophilus Influenzae Type bNeisseria Meningitidis GlaxoSmithKline 4,441
Testing effectiveness (Phase 2)Study completedNCT00289796What this trial is testingAssess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib VaccineWho this might be right forHepatitis B GlaxoSmithKline 121
Post-approval studies (Phase 4)Study completedNCT00753649What this trial is testingImmunogenicity and Safety of GSK Biologicals' Infanrix Hexa in InfantsWho this might be right forHepatitis BTetanusPoliomyelitis+3 more GlaxoSmithKline 224
Testing effectiveness (Phase 2)Study completedNCT00127855What this trial is testingDose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) VaccineWho this might be right forHaemophilus Influenzae Type bNeisseria Meningitidis GlaxoSmithKline 409
Large-scale testing (Phase 3)Study completedNCT02096263What this trial is testingStudy to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy InfantsWho this might be right forPoliomyelitisDiphtheriaHaemophilus Influenzae Type b+3 more GlaxoSmithKline 585
Post-approval studies (Phase 4)Study completedNCT00325156What this trial is testingAssess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy InfantsWho this might be right forDiphtheriaTetanusPoliomyelitis+3 more GlaxoSmithKline 2,590
Post-approval studies (Phase 4)Not Yet RecruitingNCT06748612What this trial is testingImmunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)Who this might be right forPolio International Centre for Diarrhoeal Disease Research, Bangladesh 1,190
Testing effectiveness (Phase 2)Study completedNCT00291967What this trial is testingAssess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to InfantsWho this might be right forDiphtheriaTetanusPertussis+3 more GlaxoSmithKline 525
Large-scale testing (Phase 3)Study completedNCT00654901What this trial is testingStudy of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™Who this might be right forDiphtheriaTetanusPertussis+3 more Sanofi Pasteur, a Sanofi Company 881
Testing effectiveness (Phase 2)Study completedNCT01453998What this trial is testingSafety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)Who this might be right forAcellular PertussisHepatitis BHaemophilus Influenzae Type b+3 more GlaxoSmithKline 657
Large-scale testing (Phase 3)Study completedNCT00197236What this trial is testingImmunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 MonthsWho this might be right forHepatitis A GlaxoSmithKline 468